Terms: = Lymphoma AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Treatment
24495 results:
1. A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.
Kilickap S; Ozturk A; Karadurmus N; Korkmaz T; Yumuk PF; Cicin I; Paydas S; Cilbir E; Sakalar T; Uysal M; Yesil Cinkir H; Uskent N; Demir N; Sakin A; Dursun OU; Aver B; Turhal NS; Keskin S; Tural D; Eralp Y; Bugdayci Basal F; Yasar HA; Sendur MAN; Demirci U; Cubukcu E; Karaagac M; Cakar B; Tatli AM; Yetisyigit T; Urvay S; Gursoy P; Oyan B; Turna ZH; Isikdogan A; Olmez OF; Yazici O; Cabuk D; Seker MM; Unal OU; Meydan N; Okutur SK; Tunali D; Erman M;
Medicine (Baltimore); 2024 May; 103(21):e37972. PubMed ID: 38787994
[TBL] [Abstract] [Full Text] [Related]
2. Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: A case report and literature review.
Zhong Q; Yan Y; Li S
Medicine (Baltimore); 2024 May; 103(21):e38303. PubMed ID: 38787969
[TBL] [Abstract] [Full Text] [Related]
3. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
[TBL] [Abstract] [Full Text] [Related]
4. FAT1 inhibits the proliferation of DLBCL cells via increasing the m
Wang TL; Miao XJ; Shuai YR; Sun HP; Wang X; Yang M; Zhang N
Sci Rep; 2024 May; 14(1):11836. PubMed ID: 38782965
[TBL] [Abstract] [Full Text] [Related]
5. Clinical pharmacokinetics and pharmacodynamics of venetoclax, a selective B-cell lymphoma-2 inhibitor.
Salem AH; Menon RM
Clin Transl Sci; 2024 May; 17(5):e13807. PubMed ID: 38778732
[TBL] [Abstract] [Full Text] [Related]
6. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
7. Surgical outcomes of robotic thyroidectomy for thyroid tumors over 4 cm via the bilateral axillo-breast approach.
Bae HL; Wong JS; Kim SJ; Jung Y; Choi JB; Kwak J; Yu HW; Chai YJ; Choi JY; Lee KE
Sci Rep; 2024 May; 14(1):11646. PubMed ID: 38773181
[TBL] [Abstract] [Full Text] [Related]
8. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy.
Nakamura N; Jo T; Arai Y; Kitawaki T; Nishikori M; Mizumoto C; Kanda J; Yamashita K; Nagao M; Takaori-Kondo A
Clin Exp Med; 2024 May; 24(1):105. PubMed ID: 38771501
[TBL] [Abstract] [Full Text] [Related]
9. Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment.
Lougaris V; Piane FL; Cancrini C; Conti F; Tommasini A; Badolato R; Trizzino A; Zecca M; De Rosa A; Barzaghi F; Pignata C
Ital J Pediatr; 2024 May; 50(1):103. PubMed ID: 38769568
[TBL] [Abstract] [Full Text] [Related]
10. treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin lymphoma.
McCormick BJ; Zieman D; Sluzevich JC; Alhaj Moustafa M
J Investig Med High Impact Case Rep; 2024; 12():23247096241255840. PubMed ID: 38767173
[TBL] [Abstract] [Full Text] [Related]
12. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
[TBL] [Abstract] [Full Text] [Related]
13. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
Zhou F; Du F; Wang Z; Xue M; Wu D; Chen S; He X
J Hematol Oncol; 2024 May; 17(1):34. PubMed ID: 38764055
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.
Kwak K; Park Y; Kim BS; Kang KW
Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
[TBL] [Abstract] [Full Text] [Related]
15. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
Gao Y; He H; Li X; Zhang L; Xu W; Feng R; Li W; Xiao Y; Liu X; Chen Y; Wang X; Bai B; Wu H; Cai Q; Li Z; Li J; Lin S; He Y; Ping L; Huang C; Mao J; Chen X; Zhao B; Huang H
Signal Transduct Target Ther; 2024 May; 9(1):121. PubMed ID: 38755119
[TBL] [Abstract] [Full Text] [Related]
16. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
[No Abstract] [Full Text] [Related]
17. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic Leukemia in Mexico.
Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
[TBL] [Abstract] [Full Text] [Related]
18. Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis.
Brazel D; Grant C; Cabal A; Chen WP; Pinter-Brown L
Front Immunol; 2024; 15():1334899. PubMed ID: 38745669
[TBL] [Abstract] [Full Text] [Related]
19. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q
Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265
[TBL] [Abstract] [Full Text] [Related]
20. Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers.
Georgievski A; Bellaye PS; Tournier B; Choubley H; Pais de Barros JP; Herbst M; Béduneau A; Callier P; Collin B; Végran F; Ballerini P; Garrido C; Quéré R
Cell Death Dis; 2024 May; 15(5):328. PubMed ID: 38734740
[TBL] [Abstract] [Full Text] [Related]
[Next]